These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10473081)

  • 1. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
    Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
    Tucker ON; Dannenberg AJ; Yang EK; Zhang F; Teng L; Daly JM; Soslow RA; Masferrer JL; Woerner BM; Koki AT; Fahey TJ
    Cancer Res; 1999 Mar; 59(5):987-90. PubMed ID: 10070951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides].
    Wang XP; Xie CG; Dong YW; Zhang RL; Wu LY; Wu K
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1501-4. PubMed ID: 14521730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
    Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG
    Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 is overexpressed in human cervical cancer.
    Kulkarni S; Rader JS; Zhang F; Liapis H; Koki AT; Masferrer JL; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2001 Feb; 7(2):429-34. PubMed ID: 11234900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
    Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
    Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.
    Murata H; Kawano S; Tsuji S; Tsuji M; Sawaoka H; Kimura Y; Shiozaki H; Hori M
    Am J Gastroenterol; 1999 Feb; 94(2):451-5. PubMed ID: 10022645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
    Wang HX; Chen QK
    Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
    Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
    J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
    Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
    Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 in prostate carcinoma.
    Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
    Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
    Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
    Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.
    Ohno R; Yoshinaga K; Fujita T; Hasegawa K; Iseki H; Tsunozaki H; Ichikawa W; Nihei Z; Sugihara K
    Cancer; 2001 May; 91(10):1876-81. PubMed ID: 11346869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.